Guangshi Du

422 total citations
12 papers, 238 citations indexed

About

Guangshi Du is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Oncology. According to data from OpenAlex, Guangshi Du has authored 12 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Endocrine and Autonomic Systems and 2 papers in Oncology. Recurrent topics in Guangshi Du's work include Kruppel-like factors research (4 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). Guangshi Du is often cited by papers focused on Kruppel-like factors research (4 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). Guangshi Du collaborates with scholars based in China, Hong Kong and United States. Guangshi Du's co-authors include Ling Li, Xu Song, Ceshi Chen, Yan Xiao, Fanya Zeng, Hongjun Chen, Yujie Shi, Dewei Jiang, Chuanyu Yang and Rong Liu and has published in prestigious journals such as Cell Death and Differentiation, Cancer Letters and Antiviral Research.

In The Last Decade

Guangshi Du

12 papers receiving 237 citations

Peers

Guangshi Du
Guangshi Du
Citations per year, relative to Guangshi Du Guangshi Du (= 1×) peers Tushar H. More

Countries citing papers authored by Guangshi Du

Since Specialization
Citations

This map shows the geographic impact of Guangshi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangshi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangshi Du more than expected).

Fields of papers citing papers by Guangshi Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangshi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangshi Du. The network helps show where Guangshi Du may publish in the future.

Co-authorship network of co-authors of Guangshi Du

This figure shows the co-authorship network connecting the top 25 collaborators of Guangshi Du. A scholar is included among the top collaborators of Guangshi Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangshi Du. Guangshi Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chen, Wei, Guangshi Du, Jie Gao, et al.. (2024). Microfluidic-based preparation of artificial antigen-presenting gel droplets for integrated and minimalistic adoptive cell therapy strategies. Biofabrication. 16(2). 25034–25034. 2 indexed citations
2.
Zhao, Ping, Jian Sun, Xinwei Huang, et al.. (2023). Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer. International Journal of Biological Sciences. 19(6). 1861–1874. 18 indexed citations
3.
Bai, Yunjin, et al.. (2023). A review for the impacts of circadian disturbance on urological cancers. Sleep and Biological Rhythms. 22(2). 163–180. 4 indexed citations
4.
Hu, Rong, et al.. (2023). Microfluidic Chips: Emerging Technologies for Adoptive Cell Immunotherapy. Micromachines. 14(4). 877–877. 8 indexed citations
5.
Cui, Qiuxia, Jian Sun, Jingping Yuan, et al.. (2023). DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis. Genes & Diseases. 11(1). 91–94. 7 indexed citations
6.
Li, Tao, Peng Chen, Jun Qiao, et al.. (2023). Circadian disturbance induces erectile dysfunction by impairing endothelial function. Asian Journal of Andrology. 26(2). 205–211. 4 indexed citations
7.
Shi, Yujie, Yi Wen, Zhongmei Zhou, et al.. (2021). KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1. Cancer Letters. 515. 49–62. 23 indexed citations
8.
Wang, Xinye, Ting Qiu, Yingying Wu, et al.. (2021). Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer. Cell Death and Differentiation. 28(10). 2931–2945. 42 indexed citations
9.
Fang, Huan, et al.. (2019). HDAC inhibitors induce proline dehydrogenase (POX) transcription and anti-apoptotic autophagy in triple negative breast cancer. Acta Biochimica et Biophysica Sinica. 51(10). 1064–1070. 20 indexed citations
11.
Du, Guangshi, et al.. (2017). Non-Coding Transcripts from Enhancers: New Insights into Enhancer Activity and Gene Expression Regulation. Genomics Proteomics & Bioinformatics. 15(3). 201–207. 53 indexed citations
12.
Yu, Yang, et al.. (2015). Human eukaryotic elongation factor 1A forms oligomers through specific cysteine residues. Acta Biochimica et Biophysica Sinica. 47(12). 1011–1017. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026